Reactivation of Strongyloides stercoralis in patients with SARS-CoV-2 pneumonia receiving dexamethasone
Med Clin (Barc). 2022 Mar 11;158(5):242-243.
doi: 10.1016/j.medcli.2021.05.004.
Epub 2021 May 27.
[Article in
English,
Spanish]
Affiliations
- 1 Departamento de Medicina Interna, Hospital Sant Joan Despí Moisès Broggi, Barcelona.
- 2 Centro de Atención Primaria Florida Sud, L'Hospitalet de Llobregat, Barcelona.
- 3 Departamento de Medicina Interna, Hospital Sant Joan Despí Moisès Broggi, Barcelona. Electronic address: Vanesa.anton.v@gmail.com.
No abstract available
MeSH terms
-
Animals
-
COVID-19 Drug Treatment*
-
Dexamethasone / adverse effects
-
Humans
-
Pneumonia*
-
SARS-CoV-2
-
Strongyloides stercoralis*
-
Strongyloidiasis* / diagnosis
-
Strongyloidiasis* / drug therapy